Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
TherapeuticsMD, Inc. (TXMD) had Gross Margin of 100.00% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$3.02M |
|
$-0.57M |
|
-- |
|
$3.02M |
|
$7.41M |
|
$-4.39M |
|
$3.74M |
|
$-0.65M |
|
$-0.65M |
|
$-0.65M |
|
$-0.65M |
|
$-0.57M |
|
$-0.65M |
|
$-4.39M |
|
$-3.20M |
|
11.57M |
|
11.57M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$14.45M |
|
-- |
|
$23.21M |
|
$37.66M |
|
$4.79M |
|
-- |
|
$6.00M |
|
$10.78M |
|
$26.88M |
|
$23.11M |
|
$26.88M |
|
11.57M |
|
| Cash Flow Statement Financials | |
$2.45M |
|
-- |
|
-- |
|
$5.06M |
|
$7.48M |
|
$2.42M |
|
$0.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Gross Margin |
100.00% |
-145.27% |
|
-145.27% |
|
-105.79% |
|
-21.61% |
|
-18.83% |
|
$2.45M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
0.86 |
|
425.75 |
|
-2.43% |
|
-2.83% |
|
-1.73% |
|
-2.43% |
|
$2.32 |
|
$0.21 |
|
$0.21 |
|